Credit: Getty Images. Velsipity is a sphingosine 1-phosphate (S1P) receptor modulator. The Food and Drug Administration (FDA) has approved Velsipity™ (etrasimod) for the treatment of moderately to ...
CHAPEL HILL, N.C. (Ivanhoe Newswire) – Cancer — we all know it’s a tough battle for anyone diagnosed with it. The treatments can be brutal – chemo, radiation, and surgery take a toll on the body, and ...
(RTTNews) - Novartis AG (NVS) announced that the U.S. Food and Drug Administration has approved oral Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results